538 related articles for article (PubMed ID: 24305596)
1. Assessment, origin, and implementation of breath volatile cancer markers.
Haick H; Broza YY; Mochalski P; Ruzsanyi V; Amann A
Chem Soc Rev; 2014 Mar; 43(5):1423-49. PubMed ID: 24305596
[TBL] [Abstract][Full Text] [Related]
2. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
Sun X; Shao K; Wang T
Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
[TBL] [Abstract][Full Text] [Related]
3. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
4. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
Zhou J; Huang ZA; Kumar U; Chen DDY
Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
[TBL] [Abstract][Full Text] [Related]
5. VOC breath biomarkers in lung cancer.
Saalberg Y; Wolff M
Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
[TBL] [Abstract][Full Text] [Related]
6. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
7. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
8. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
Hua Q; Zhu Y; Liu H
Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties.
Amann A; Mochalski P; Ruzsanyi V; Broza YY; Haick H
J Breath Res; 2014 Mar; 8(1):016003. PubMed ID: 24566039
[TBL] [Abstract][Full Text] [Related]
10. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
11. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
[TBL] [Abstract][Full Text] [Related]
12. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
13. Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors.
Li W; Liu HY; Jia ZR; Qiao PP; Pi XT; Chen J; Deng LH
Asian Pac J Cancer Prev; 2014; 15(11):4377-84. PubMed ID: 24969857
[TBL] [Abstract][Full Text] [Related]
14. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
Oakley-Girvan I; Davis SW
Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
[TBL] [Abstract][Full Text] [Related]
15. Graphene and metal-organic framework hybrids for high-performance sensors for lung cancer biomarker detection supported by machine learning augmentation.
Tran ATT; Hassan K; Tung TT; Tripathy A; Mondal A; Losic D
Nanoscale; 2024 May; 16(18):9084-9095. PubMed ID: 38644676
[TBL] [Abstract][Full Text] [Related]
16. Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs.
Shang G; Dinh D; Mercer T; Yan S; Wang S; Malaei B; Luo J; Lu S; Zhong CJ
ACS Sens; 2023 Mar; 8(3):1328-1338. PubMed ID: 36883832
[TBL] [Abstract][Full Text] [Related]
17. Cell culture metabolomics in the diagnosis of lung cancer-the influence of cell culture conditions.
Kalluri U; Naiker M; Myers MA
J Breath Res; 2014 Jun; 8(2):027109. PubMed ID: 24861817
[TBL] [Abstract][Full Text] [Related]
18. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
19. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
20. Modelling of Breath and Various Blood Volatilomic Profiles-Implications for Breath Volatile Analysis.
Mochalski P; King J; Mayhew CA; Unterkofler K
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
